PubMed

Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ.

Ann Intern Med. 2000 Apr 18;132(8):612-20.PMID: 10766679 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.

Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R.

Cancer. 2007 Feb 15;109(4):668-74.PMID: 17211862 [PubMed - indexed for MEDLINE]Related articlesFree article

Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma.

Oberg S, Wenner J, Johansson J, Walther B, Willén R.

Ann Surg. 2005 Jul;242(1):49-54.PMID: 15973101 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

Reid BJ, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, Levine DS, Blount PL, Rabinovitch PS.

Am J Gastroenterol. 2001 Oct;96(10):2839-48.PMID: 11693316 [PubMed - indexed for MEDLINE]Related articlesFree article

Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study.

Dong LM, Kristal AR, Peters U, Schenk JM, Sanchez CA, Rabinovitch PS, Blount PL, Odze RD, Ayub K, Reid BJ, Vaughan TL.

Nutr Cancer. 2008;60(1):39-48.PMID: 18444134 [PubMed - indexed for MEDLINE]Related articlesFree article

Short segment columnar-lined oesophagus: an underestimated cancer risk? A large cohort study of the relationship between Barrett's columnar-lined oesophagus segment length and adenocarcinoma risk.

Gatenby PA, Caygill CP, Ramus JR, Charlett A, Fitzgerald RC, Watson A.

Eur J Gastroenterol Hepatol. 2007 Nov;19(11):969-75.PMID: 18049166 [PubMed - indexed for MEDLINE]Related articles

Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years.

Hage M, Siersema PD, van Dekken H, Steyerberg EW, Dees J, Kuipers EJ.

Scand J Gastroenterol. 2004 Dec;39(12):1175-9.PMID: 15742992 [PubMed - indexed for MEDLINE]Related articles

The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma.

Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG, Blount PL, Reid BJ.

Cancer Res. 2004 Oct 15;64(20):7629-33.PMID: 15492292 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.

Bani-Hani K, Martin IG, Hardie LJ, Mapstone N, Briggs JA, Forman D, Wild CP.

J Natl Cancer Inst. 2000 Aug 16;92(16):1316-21.PMID: 10944553 [PubMed - indexed for MEDLINE]Related articlesFree article

Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.

Chao DL, Maley CC, Wu X, Farrow DC, Galipeau PC, Sanchez CA, Paulson TG, Rabinovitch PS, Reid BJ, Spitz MR, Vaughan TL.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1935-40.PMID: 17035402 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.

Weston AP, Sharma P, Mathur S, Banerjee S, Jafri AK, Cherian R, McGregor D, Hassanein RS, Hall M.

Am J Gastroenterol. 2004 Sep;99(9):1657-66.PMID: 15330898 [PubMed - indexed for MEDLINE]Related articles

[Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance]

Burdiles P, Csendes A, Smok G, Braghetto I, Korn O.

Rev Med Chil. 2003 Jun;131(6):587-96. Spanish. PMID: 12942585 [PubMed - indexed for MEDLINE]Related articles

Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.

Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL.

Am J Gastroenterol. 2005 Apr;100(4):775-83.PMID: 15784018 [PubMed - indexed for MEDLINE]Related articles

Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.

Vieth M, Schubert B, Lang-Schwarz K, Stolte M.

Endoscopy. 2006 Dec;38(12):1201-5.PMID: 17163319 [PubMed - indexed for MEDLINE]Related articles

Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.

Lomo LC, Blount PL, Sanchez CA, Li X, Galipeau PC, Cowan DS, Ayub K, Rabinovitch PS, Reid BJ, Odze RD.

Am J Surg Pathol. 2006 Apr;30(4):423-35.PMID: 16625087 [PubMed - indexed for MEDLINE]Related articles

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.

Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, Hamilton J, Kan T, Krasna MJ, Beer DG, Pepe MS, Abraham JM, Feng Z, Schmiegel W, Greenwald BD, Meltzer SJ.

Oncogene. 2005 Jun 9;24(25):4138-48.PMID: 15824739 [PubMed - indexed for MEDLINE]Related articles

Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.

Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ.

Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):745-52.PMID: 12163328 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS.

Am J Gastroenterol. 2000 Jul;95(7):1669-76.PMID: 10925966 [PubMed - indexed for MEDLINE]Related articlesFree article

Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.

Siahpush SH, Vaughan TL, Lampe JN, Freeman R, Lewis S, Odze RD, Blount PL, Ayub K, Rabinovitch PS, Reid BJ, Chen C.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2387-95.PMID: 18006928 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.

Gopal DV, Lieberman DA, Magaret N, Fennerty MB, Sampliner RE, Garewal HS, Falk GW, Faigel DO.

Dig Dis Sci. 2003 Aug;48(8):1537-41.PMID: 12924649 [PubMed - indexed for MEDLINE]Related articles